Severity of COVID-19 and Treatment Strategy for Patient With Diabetes
Coronavirus disease 2019 (COVID-19), which was named by the World Health Organization (WHO) in February 2020, has quickly spread to more than 200 countries around the world and was declared as a global pandemic in March 2020. The severity of the disease makes it more prone to severe symptoms and hig...
Main Authors: | Shi Jin, Weina Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.602735/full |
Similar Items
-
A RETROSPECTIVE OBSERVATIONAL STUDY ON THE EFFECTS OF TYPE 2 DIABETES AND ITS MANAGEMENT ON INDIVIDUALS WITH SEVERE COVID-19 PATIENTS’ PROGNOSIS.
by: Shaibal Guha, et al.
Published: (2023-06-01) -
Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
by: Jiayu Zhang, et al.
Published: (2023-10-01) -
Severe COVID-19: what have we learned with the immunopathogenesis?
by: Bruno Bordallo, et al.
Published: (2020-09-01) -
Exploring NFkB pathway as a potent strategy to mitigate COVID-19 severe morbidity and mortality
by: Mubarak Muhammad, et al.
Published: (2022-10-01) -
Glycemic Dysregulation, Inflammation and Disease Outcomes in Patients Hospitalized with COVID-19: Beyond Diabetes and Obesity
by: Angelos Liontos, et al.
Published: (2023-06-01)